Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer

Figure 1

Comparison of raw circulating levels of MMP-1 across individuals diagnosed with benign prostate hyperplasia (BPH) or prostate cancer (PCa). Significance was verified by the partial correlation test controlled for all three rs495366 genotypes. Vertical bars represent intervals of one standard error. ^#The effect size (d) is 1.57, and 95% confidence interval is (0.3; 0.6) for BPH and (0.5; 1.4) for PCa.